Molecular and cellular stratagem of brain metastases associated with melanoma.
blood-brain barrier
brain metastases
immune status
melanoma
Journal
Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
received:
06
09
2018
accepted:
17
12
2018
entrez:
5
4
2019
pubmed:
5
4
2019
medline:
5
4
2019
Statut:
ppublish
Résumé
Tumors of the central nervous system are the most prevalent complications of melanoma, especially in the late stage of disease. Melanoma, lung and breast cancer are the leading cause of secondary tumors in the brain, the majority of them having a poor outcome. Brain dissemination is developed in half of stage IV melanomas and these cases can increase up to 75%, having a major impact on the quality of life. This review will focus on recent findings that provide new ways to potentially prevent brain metastases in malignant melanoma. The key of these findings is based on the heterogeneity of the melanoma and of the brain metastases at genetic levels. This new era of technologies provides new tools in understanding the dissemination mechanisms of malignant cells. The cellular and molecular changes, the immune status of the patient and the blood-brain barrier permeability are key regulators of cancer cell dissemination. Understanding these mechanisms can render new hope in preventing brain metastases by focusing on melanoma and new pharmacologic approaches.
Identifiants
pubmed: 30944612
doi: 10.3892/ol.2019.9933
pii: OL-0-0-9933
pmc: PMC6444343
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
4170-4175Références
Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13312-7
pubmed: 11606789
Cancer Res. 2006 Mar 15;66(6):3188-96
pubmed: 16540670
Dev Neurobiol. 2007 Sep 1;67(10):1348-61
pubmed: 17638387
Pigment Cell Melanoma Res. 2009 Feb;22(1):86-98
pubmed: 19017294
J Clin Oncol. 2008 Dec 20;26(36):5950-6
pubmed: 19018089
Nat Genet. 2009 May;41(5):544-52
pubmed: 19282848
Expert Rev Dermatol. 2008 Oct;3(5):569-585
pubmed: 19649148
Int J Cancer. 2010 Jun 1;126(11):2553-62
pubmed: 19830692
Clin Cancer Res. 2009 Dec 15;15(24):7538-7546
pubmed: 19996208
J Transl Med. 2010 Jun 11;8:56
pubmed: 20540720
J Invest Dermatol. 2011 Mar;131(3):719-26
pubmed: 21150923
Semin Cancer Biol. 2011 Apr;21(2):107-12
pubmed: 21167939
J Cancer Res Ther. 2011 Jan-Mar;7(1):47-51
pubmed: 21546742
Ann Biomed Eng. 2011 Aug;39(8):2223-2241
pubmed: 21556948
PLoS One. 2011;6(6):e20758
pubmed: 21674054
Int J Cancer. 2012 Sep 1;131(5):1071-82
pubmed: 22025079
Int J Mol Sci. 2013 Jan 11;14(1):1383-411
pubmed: 23344048
Rom J Morphol Embryol. 2013;54(1):51-62
pubmed: 23529309
Curr Oncol Rep. 2013 Oct;15(5):483-91
pubmed: 23954973
Cancer Med. 2013 Feb;2(1):76-85
pubmed: 24133630
Neuro Oncol. 2014 Apr;16(4):540-51
pubmed: 24311639
Cell. 2014 Feb 27;156(5):1002-16
pubmed: 24581498
N Engl J Med. 2014 Nov 13;371(20):1867-76
pubmed: 25265494
J Pathol. 2015 May;236(1):116-27
pubmed: 25639230
Oncologist. 2015 Jul;20(7):789-97
pubmed: 25956405
Clin Cancer Res. 2015 Nov 1;21(21):4903-12
pubmed: 26089374
Oncologist. 2015 Sep;20(9):1011-8
pubmed: 26205736
Nature. 2015 Nov 5;527(7576):100-104
pubmed: 26479035
J Mol Med (Berl). 2015 Nov;93(11):1213-20
pubmed: 26489608
Oncotarget. 2015 Dec 29;6(42):44254-73
pubmed: 26497551
Epigenomics. 2015;7(8):1303-11
pubmed: 26638944
Food Chem Toxicol. 2016 May;91:42-57
pubmed: 26969113
Oncol Rep. 2016 May;35(5):2516-28
pubmed: 26986013
Oncol Lett. 2016 May;11(5):3354-3360
pubmed: 27123116
PLoS One. 2016 May 23;11(5):e0156115
pubmed: 27213536
Cancer Res. 2016 Aug 1;76(15):4359-71
pubmed: 27261506
Clin Cancer Res. 2016 Dec 1;22(23):5818-5828
pubmed: 27307593
Arch Toxicol. 2017 Mar;91(3):1031-1048
pubmed: 27438349
J Transl Med. 2016 Oct 19;14(1):297
pubmed: 27756426
Onco Targets Ther. 2016 Dec 12;9:7149-7159
pubmed: 28003758
Oncotarget. 2017 May 9;8(19):31079-31091
pubmed: 28415693
Part Fibre Toxicol. 2017 Jun 24;14(1):22
pubmed: 28646905
Oncol Rep. 2017 Sep;38(3):1327-1340
pubmed: 28713981
Sci Rep. 2017 Aug 18;7(1):8864
pubmed: 28821754
Food Chem Toxicol. 2018 Jan;111:546-556
pubmed: 29191727
PLoS One. 2018 Jan 16;13(1):e0191102
pubmed: 29338016
Nanomedicine (Lond). 2018 Apr 1;13(7):703-715
pubmed: 29629829
PeerJ. 2018 May 29;6:e4763
pubmed: 29868251